This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
CNO Q2 Earnings Beat Estimates on Strong Annuity Collected Premiums
by Zacks Equity Research
CNO Financial's Q2 earnings benefit from growth in annuity and health premiums, and rising fee income, partly offset by an elevated expense level. It still expects 2025 operating EPS within $3.70-$3.90.
Top Stock Reports for Costco, HSBC & Booking Holdings
by Mark Vickery
COST, HSBC, and BKNG are gaining ground with strong strategies, solid results, and standout performance vs. peers.
Everest Group Q2 Earnings Beat Estimates, Revenues Increase Y/Y
by Zacks Equity Research
EG beats Q2 estimates with $17.36 EPS and $4.5B revenue, as investment income and reinsurance edge up.
Prudential Financial Q2 Earnings Beat Estimates, Revenues Decline Y/Y
by Zacks Equity Research
PRU beats Q2 estimates with EPS of $3.58 and $13.5B in revenues, despite a year-over-year decline in revenues.
Arch Capital Q2 Earnings Beat Estimates on Higher Premiums
by Zacks Equity Research
ACGL tops Q2 estimates as premiums and investment income rise, lifting revenues nearly 21% year over year.
Arch Capital (ACGL) Reports Q2 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
The headline numbers for Arch Capital (ACGL) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Arch Capital Group (ACGL) Tops Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Arch Capital (ACGL) delivered earnings and revenue surprises of +11.69% and +2.62%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Can ACGL's New Health Suite Boost Growth and Expand Market Reach?
by Zacks Equity Research
Arch Capital launches a flexible supplemental health suite aimed at gig workers and independents to boost growth and diversify revenues.
Universal Insurance Holdings (UVE) Q2 Earnings and Revenues Top Estimates
by Zacks Equity Research
Universal Insurance (UVE) delivered earnings and revenue surprises of +12.84% and +11.16%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
What's in the Cards for Arch Capital This Earnings Season?
by Zacks Equity Research
ACGL's Q2 results are likely to reflect rate increases, new business opportunities, growth in invested asset base, and improved pricing.
Selective Insurance (SIGI) Lags Q2 Earnings Estimates
by Zacks Equity Research
Selective Insurance (SIGI) delivered earnings and revenue surprises of -15.48% and +0.90%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Hanover Insurance Group (THG) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Hanover Insurance (THG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Arch Capital Group (ACGL) Surpasses Market Returns: Some Facts Worth Knowing
by Zacks Equity Research
Arch Capital Group (ACGL) concluded the recent trading session at $89, signifying a +1.66% move from its prior day's close.
Earnings Preview: Arch Capital Group (ACGL) Q2 Earnings Expected to Decline
by Zacks Equity Research
Arch Capital (ACGL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Kinsale Capital Trades Above 50-Day SMA: Time to Buy the Stock?
by Zacks Equity Research
KNSL stock trades above its 50-day SMA, signaling bullish momentum despite a pullback from 52-week highs.
Arch Capital Group (ACGL) Sees a More Significant Dip Than Broader Market: Some Facts to Know
by Zacks Equity Research
Arch Capital Group (ACGL) closed the most recent trading day at $88.19, moving 2.65% from the previous trading session.
Is a Beat in Store for Progressive This Earnings Season?
by Zacks Equity Research
PGR eyes a 62.3% earnings jump and 17.9% revenue growth in Q2, with solid premiums and investment gains driving momentum.
Is a Beat in the Cards for Travelers This Earnings Season?
by Zacks Equity Research
TRV's Q2 results are likely to reflect solid renewal rate change, strong retention in high-quality Management Liability business and higher long-term average yields.
Arch Capital Group (ACGL) Stock Declines While Market Improves: Some Information for Investors
by Zacks Equity Research
The latest trading day saw Arch Capital Group (ACGL) settling at $87.92, representing a -2.54% change from its previous close.
How to Boost Your Portfolio with Top Finance Stocks Set to Beat Earnings
by Zacks Equity Research
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Arch Capital Group (ACGL) Stock Sinks As Market Gains: Here's Why
by Zacks Equity Research
Arch Capital Group (ACGL) closed at $88.38 in the latest trading session, marking a -3.41% move from the prior day.
Will Arch Capital (ACGL) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
Arch Capital (ACGL) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
MCY Outperforms Industry, Trades at Premium: How to Play the Stock
by Zacks Equity Research
Mercury General stock gains from rate increases, higher average invested assets, financial flexibility, favorable estimates and attractive valuation.
CNA Stock Trading at a Discount to Industry at 1.22X: Time to Hold?
by Zacks Equity Research
CNA Financial is poised to gain from solid retention, favorable renewal premium change and new business growth across Specialty, Commercial and International segments.
PLMR Outperforms Industry, Trades at Premium: How to Play the Stock
by Zacks Equity Research
Palomar Holdings is poised to gain from its fee-based platform, rising crop premiums, Surety expansion and debt-free balance sheet backed by strong reinsurance strategy.